Sunday, March 20, 2005

Post-market surveillance of drugs inadequate, study suggests

From the Canadian Press:
A study of drugs withdrawn from the Canadian market over the last four decades uncovers some worrisome facts - and some surprising gaps in regulatory information, a commentary published Tuesday in the Canadian Medical Association Journal suggests.

Health Canada doesn't keep a list of drugs removed from the market for safety reasons, nor is there clear information on what should trigger a safety withdrawal, said author Dr. Joel Lexchin, a long-term critic of the pharmaceutical industry. ...more

No comments: